The substance of Richard Asinof’s article on ConvergenceRI is definitely worthy of note:

But the team of researchers working at MindImmune, a drug development enterprise working out of the University of Rhode Island, recently announced plans to produce a new drug candidate, MITI-101, to seek to counteract Alzheimer’s disease with a treatment that targets immune cells in the blood – and then possibly to repair damaged neurons in the synaptic process. The plan is to bring the drug candidate to the clinic in 2026, culminating a remarkable 30-year scientific research journey.

Click through and read the article/interview; I’d suggest, however, you skip to the second paragraph.  I make this recommendation because the first paragraph is so peculiarly distracting.  The reason the blockquote above starts with “but” is that Asimov, for no reason, puts this potential medical breakthrough in the context of recent debates about acetaminophen during pregnancy.

He even complains that the topic with which he distracts from his own story is “made-for-distraction”!

Maybe brain researchers at our local colleges could investigate this strange mind virus that seems to be going around.